shockedcanadian
Diamond Member
- Aug 6, 2012
- 34,575
- 32,115
- 2,905
I have a great deal of catching up to do.
Top executives at two of the biggest Covid-19 vaccine manufacturers are split over how necessary a fourth dose is for most of the world’s population.
Pfizer Inc. Chief Executive Officer Albert Bourla said in a CBS interview on Sunday that protection from three shots will wane and a fourth dose is needed “right now”. Then, in an interview, Moderna Inc. President Stephen Hoge said a second booster is probably only necessary for older people or those who are immunocompromised, with the rest of the public able to be more selective about receiving the shot, Business Insider reported Monday.
Both men agreed that the virus is here to stay.
A fourth dose of the Pfizer-BioNTech vaccine was insufficient to prevent infection with omicron, though it gave a partial defence against the strain, according to preliminary data from a trial in Israel released in January. The country, along with South Korea, is one of the few to be giving fourth doses and so far only for the most vulnerable.
Pfizer CEO says fourth dose needed ‘right now’ after data warns of new bump in COVID cases
A fourth dose of Pfizer was insufficient to prevent infection with omicron, though it gave a partial defence against the strain
nationalpost.com
Top executives at two of the biggest Covid-19 vaccine manufacturers are split over how necessary a fourth dose is for most of the world’s population.
Pfizer Inc. Chief Executive Officer Albert Bourla said in a CBS interview on Sunday that protection from three shots will wane and a fourth dose is needed “right now”. Then, in an interview, Moderna Inc. President Stephen Hoge said a second booster is probably only necessary for older people or those who are immunocompromised, with the rest of the public able to be more selective about receiving the shot, Business Insider reported Monday.
Both men agreed that the virus is here to stay.
A fourth dose of the Pfizer-BioNTech vaccine was insufficient to prevent infection with omicron, though it gave a partial defence against the strain, according to preliminary data from a trial in Israel released in January. The country, along with South Korea, is one of the few to be giving fourth doses and so far only for the most vulnerable.